News Detail

This Vertex Pharmaceuticals Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday

Benzinga · 6d ago

Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Compass Point analyst Joe Flynn downgraded the rating for MARA Holdings, Inc. (NASDAQ:MARA) from Neutral to Sell and lowered the price target from $25 to $9.5. MARA Holdings shares closed at $13.09 on Monday. See how other analysts view this stock.
Leerink Partners analyst David Risinger downgraded Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) from Outperform to Market Perform and cut the price target from $550 to $503. Vertex Pharmaceuticals shares closed at $500.19 on Monday. See how other analysts view this stock.
Citigroup analyst Jenny Ping downgraded the rating for National Grid plc (NYSE:NGG) from Buy to Neutral. National Grid shares closed at $71.84 on Monday. See how other analysts view this stock.
JWedbush analyst Michael Pachter downgraded Turtle Beach Corporation (NASDAQ:TBCH) from Outperform to Neutral and lowered the price target from $21 to $9. Turtle Beach shares closed at $10.76 on Monday. See how other analysts view this stock.

Considering buying VRTX stock? Here’s what analysts think:

Read This Next:

Jim Cramer Says Applied Materials Is An ‘Excellent’ Company, But Likes This Tech Stock More

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.